ChemoCentryx
Utility Patent Applications
Last updated:
List of all ChemoCentryx patents 72 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF TREATING GENERALIZED PUSTULAR PSORIASIS WITH AN ANTAGONIST OF CCR6 OR CXCR2 Filling date: 8 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: TREATMENT OF C3 GLOMERULOPATHY USING A C5A INHIBITOR Filling date: 8 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: CAPSULE FORMULATIONS Filling date: 8 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: METHOD OF TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: SUBSTITUTED ANILINES AS CCR(4) ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: INDANE-AMINES AS PD-L1 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS Filling date: 8 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: METHODS OF TREATING HIDRADENITIS SUPPURATIVA Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: CXCR7 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: MACROCYCLIC IMMUNOMODULATORS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: AZA-ARYL 1H-PYRAZOL-1-YL BENZENE SULFONAMIDES Filling date: 8 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: METHODS OF TREATING RESPIRATORY DISEASES USING C5a INHIBITORS Filling date: 8 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: INHIBITORS OF CXCR2 Filling date: 8 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: METHODS OF TREATING PANCREATIC CANCER Filling date: 8 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES Filling date: 8 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING A COMBINATION THERAPY OF SMALL MOLECULE INHIBITORS OF C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES Filling date: 8 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES Filling date: 8 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: DEUTERATED COMPOUNDS AS IMMUNOMODULATORS Filling date: 8 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: C5AR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH SMALL MOLECULE PD-L1 INHIBITORS Filling date: 8 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Compositions and Methods for Treating CCR9-Mediated Diseases using CCR9 Inhibitor and Anti-TNF-Alpha Blocking Antibodies Filling date: 8 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: IMMUNOMODULATOR COMPOUNDS Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: SALT FORMS OF A COMPLEMENT COMPONENT C5A RECEPTOR Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: AMORPHOUS FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: 2-OXINDOLE COMPOUNDS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: DIAZOLE LACTAMS Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: IMMUNOMODULATOR COMPOUNDS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: DIARYL SUBSTITUTED 5,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: INDANES AS PD-L1 INHIBITORS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: 5-5 FUSED RINGS AS C5a INHIBITORS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH CCR2 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: INDANE-AMINES AS PD-L1 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: 6-5 FUSED RINGS AS C5a INHIBITORS Filling date: 8 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: Method of Treating Focal Segmental Glomerulosclerosis Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor Filling date: 8 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1 INHIBITORS OR PD-L1 INHIBITORS Filling date: 8 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING A COMBINATION THERAPY OF SMALL MOLECULE INHIBITORS OF C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES Filling date: 8 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: Method of Treating Liver Fibrosis Filling date: 8 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: SOLUBLE C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 20 Aug 2020 |
Showing 1 to 50 of 72 patents.